Summary of Study ST000407
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000319. The data can be accessed directly via it's Project DOI: 10.21228/M8H029 This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
Study ID | ST000407 |
Study Title | Arsenic and the fecal metabolome |
Study Summary | The goal of this study was to identify metabolic differences between 6 week old and 1 year old infants that have been potentially exposed to arsenic in order to determine its effect on the microbiome and the immune system. |
Institute | RTI International |
Laboratory | Systems and Translational Sciences |
Last Name | Sumner |
First Name | Susan |
Address | 3040 E. Cornwallis Road |
jpb@rti.org | |
Phone | 919-541-6700 |
Submit Date | 2016-06-02 |
Raw Data Available | Yes |
Raw Data File Type(s) | 1r |
Analysis Type Detail | NMR |
Release Date | 2018-08-27 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
Project ID: | PR000319 |
Project DOI: | doi: 10.21228/M8H029 |
Project Title: | Metabolomics Changes in the feces of infants exposed to arsenic |
Project Summary: | Exposure to arsenic (As) during the vulnerable window of fetal development and early childhood has shown significant clinical effects. In highly exposed populations, altered immunity is one of the most affected pathways and can lead to an elevated risk of infection and a pre-disposition to allergy/atopy. Since well water in the New Hampshire region has been determined to be a potential source of As exposure, this study includes mother-infant dyads living in the area, who obtain household water from private wells. This study seeks to determine if in utero and early life As exposure is related to increase occurrence of childhood: infections, allergy and atopy, and diminished vaccine response. It has been observed that the microbiome is an important mediator of immune impairment due to As exposure. Therefore, we will further investigate the relation between in utero and early life As exposure on the development of the infant intestinal microbiome in the first year of life. For this study fecal samples, from infants at risk of As exposure, were collected at 6 weeks and 12 months of age. Metabolomics data will allow for a more complete picture of the relationships between the microbiome, As exposure and immune function. |
Institute: | Dartmouth College |
Department: | Department of Epidemiology |
Last Name: | Margaret |
First Name: | Karagas |
Address: | One Medical Center Road, 7927 HB, Rubin Building, Lebanon, NH 03756 |
Email: | Margaret.Karagas@Dartmouth.edu |
Phone: | 603-653-9010 |
Subject:
Subject ID: | SU000428 |
Subject Type: | Human |
Subject Species: | Homo sapiens |
Taxonomy ID: | 9606 |
Species Group: | Human |
Factors:
Subject type: Human; Subject species: Homo sapiens (Factor headings shown in green)
mb_sample_id | local_sample_id | Age |
---|---|---|
SA019573 | P_28 | |
SA019574 | P_29 | |
SA019575 | P_27 | |
SA019576 | P_25 | |
SA019577 | P_24 | |
SA019578 | P_3 | |
SA019579 | P_26 | |
SA019580 | P_30 | |
SA019581 | P_7 | |
SA019582 | P_1 | |
SA019583 | P_6 | |
SA019584 | P_5 | |
SA019585 | P_4 | |
SA019586 | P_23 | |
SA019587 | P_9 | |
SA019588 | P_14 | |
SA019589 | P_15 | |
SA019590 | P_13 | |
SA019591 | P_12 | |
SA019592 | P_10 | |
SA019593 | P_22 | |
SA019594 | P_16 | |
SA019595 | P_11_R | |
SA019596 | P_17 | |
SA019597 | P_21 | |
SA019598 | P_20 | |
SA019599 | P_2 | |
SA019600 | P_18 | |
SA019601 | P_19 | |
SA019602 | S_26_1Y | 1Y |
SA019603 | S_259_1Y | 1Y |
SA019604 | S_263_1Y | 1Y |
SA019605 | S_264_1Y | 1Y |
SA019606 | S_260_1Y | 1Y |
SA019607 | S_255_1Y | 1Y |
SA019608 | S_267_1Y | 1Y |
SA019609 | S_249_1Y | 1Y |
SA019610 | S_251_1Y | 1Y |
SA019611 | S_252_1Y | 1Y |
SA019612 | S_256_1Y | 1Y |
SA019613 | S_254_1Y | 1Y |
SA019614 | S_258_1Y | 1Y |
SA019615 | S_278_1Y | 1Y |
SA019616 | S_284_1Y | 1Y |
SA019617 | S_283_1Y | 1Y |
SA019618 | S_285_1Y | 1Y |
SA019619 | S_288_1Y | 1Y |
SA019620 | S_246_1Y | 1Y |
SA019621 | S_282_1Y | 1Y |
SA019622 | S_28_1Y | 1Y |
SA019623 | S_272_1Y | 1Y |
SA019624 | S_271_1Y | 1Y |
SA019625 | S_273_1Y | 1Y |
SA019626 | S_274_1Y | 1Y |
SA019627 | S_275_1Y | 1Y |
SA019628 | S_268_1Y | 1Y |
SA019629 | S_227_1Y | 1Y |
SA019630 | S_222_1Y | 1Y |
SA019631 | S_221_1Y | 1Y |
SA019632 | S_224_1Y | 1Y |
SA019633 | S_226_1Y | 1Y |
SA019634 | S_289_1Y | 1Y |
SA019635 | S_218_1Y | 1Y |
SA019636 | S_217_1Y | 1Y |
SA019637 | S_212_R_1Y | 1Y |
SA019638 | S_210_1Y | 1Y |
SA019639 | S_213_1Y | 1Y |
SA019640 | S_214_1Y | 1Y |
SA019641 | S_216_1Y | 1Y |
SA019642 | S_22_R_1Y | 1Y |
SA019643 | S_230_1Y | 1Y |
SA019644 | S_240_1Y | 1Y |
SA019645 | S_24_1Y | 1Y |
SA019646 | S_241_1Y | 1Y |
SA019647 | S_242_1Y | 1Y |
SA019648 | S_244_1Y | 1Y |
SA019649 | S_239_1Y | 1Y |
SA019650 | S_237_1Y | 1Y |
SA019651 | S_232_1Y | 1Y |
SA019652 | S_231_1Y | 1Y |
SA019653 | S_234_1Y | 1Y |
SA019654 | S_235_1Y | 1Y |
SA019655 | S_236_1Y | 1Y |
SA019656 | S_245_1Y | 1Y |
SA019657 | S_307_1Y | 1Y |
SA019658 | S_65_1Y | 1Y |
SA019659 | S_61_1Y | 1Y |
SA019660 | S_7_1Y | 1Y |
SA019661 | S_71_1Y | 1Y |
SA019662 | S_73_1Y | 1Y |
SA019663 | S_60_1Y | 1Y |
SA019664 | S_58_1Y | 1Y |
SA019665 | S_52_1Y | 1Y |
SA019666 | S_50_1Y | 1Y |
SA019667 | S_53_1Y | 1Y |
SA019668 | S_55_1Y | 1Y |
SA019669 | S_57_1Y | 1Y |
SA019670 | S_74_1Y | 1Y |
SA019671 | S_76_1Y | 1Y |
SA019672 | S_92_1Y | 1Y |
Collection:
Collection ID: | CO000422 |
Collection Summary: | Feces collected from 6W and 1Y infants in the New Hampshire Birth Cohort |
Sample Type: | Feces |
Treatment:
Treatment ID: | TR000442 |
Treatment Summary: | None |
Sample Preparation:
Sampleprep ID: | SP000435 |
Sampleprep Summary: | The samples of thawed feces from each participant were transferred to massed MagNA tubes, frozen, and lyophilized. Lyophilized samples were massed and phosphate buffer was added depending on the mass of each sample (500 µL for up to 200 mg, and 1.0 mL for over 200 mg of feces) and homogenized in 30 second pulses at 2000 rpm. Homogenized samples were centrifuged and the supernatant was filtered. A volume of the filtered supernatant necessary to analyze 25 mg per sample was mixed with 70 µL of Chenomx ISTD solution, and a calculated volume of 0.5 mM phosphate buffer (pH 7.5) needed to bring the total sample volume to 630 µL. The tubes were vortexed for 2 min on a multi-tube vortexer and centrifuged at 16,000 rcf for 5 min. A 600 µl aliquot of the supernatant was transferred into pre-labeled 5mm NMR tubes for data acquisition on a 700 MHz spectrometer. Additionally, ten random QC pools were created from the samples with adequate mass to spare. An aliquot containing 5 mg of fecal water from each individual sample was transferred into the pools, and three replicates were created from each pool for a total of 30 pooled samples. Each pool was run once a day over the 3 day experimental run time. |
Analysis:
Analysis ID: | AN000647 |
Analysis Type: | NMR |
Num Factors: | 3 |
NMR:
NMR ID: | NM000069 |
Analysis ID: | AN000647 |
Instrument Name: | Bruker Avance III |
Instrument Type: | FT-NMR |
NMR Experiment Type: | 1D 1H |
Spectrometer Frequency: | 700 MHz |